ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells

Biochim Biophys Acta. 2006 Sep;1762(9):828-34. doi: 10.1016/j.bbadis.2006.07.010. Epub 2006 Jul 31.

Abstract

In the present study, increased levels of ANKHD1 mRNA and protein expression in leukemia cell lines are reported, as compared with normal hematopoietic cells. Furthermore, a higher expression of ANKHD1 mRNA was detected in primary acute leukemia samples than in normal hematopoietic cells (P=0.002). ANKHD1 was detected in the cytosolic and membrane fraction of cells and was co-immunoprecipitated with SHP2 in protein extracts of K562 and LNCaP cell lines. These findings suggest a role for ANKHD1 as a scaffolding protein that may be associated with the abnormal phenotype of leukemia cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Ankyrin Repeat*
  • Case-Control Studies
  • Cell Line, Tumor
  • Cytoplasm / metabolism
  • Gene Expression Regulation, Neoplastic*
  • HL-60 Cells
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • K562 Cells
  • Leukemia / metabolism*
  • Middle Aged
  • Protein Serine-Threonine Kinases / metabolism*
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatases / metabolism*
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Intracellular Signaling Peptides and Proteins
  • RNA, Messenger
  • ANKK1 protein, human
  • Protein Serine-Threonine Kinases
  • PTPN11 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatases